Average Co-Inventor Count = 3.94
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Dana-farber-cancer Institute Inc. (18 from 1,206 patents)
2. Cornell University (3 from 1,360 patents)
3. Voronoi Inc. (3 from 9 patents)
4. Children's Medical Center Corporation (1 from 1,036 patents)
18 patents:
1. 12479847 - Pyrrolopyrimidine inhibitors of wild-type and mutant forms of LRRK2
2. 12410194 - Potent and selective azaindole inhibitors of CDK8 and CDK19
3. 12325725 - Cyclin-dependent kinase degraders and methods of use
4. 12275731 - Azaindole inhibitors of wild-type and mutant forms of LRRK2
5. 12233128 - Degraders that target ALK and therapeutic uses thereof
6. 12157738 - Macrocyclic inhibitors of ALK, TRKA, TRKB, and ROS1
7. 12157741 - Macrocyclic inhibitors of DYRK1A
8. 11945816 - Inhibitors of EGFR and/or HER2 and methods of use
9. 11858897 - Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK and SRPK
10. 11542251 - IRAK degraders and uses thereof
11. 11248007 - Inhibitors of MALT1 and uses thereof
12. 11186574 - Inhibitors of EGFR and/or HER2 and methods of use
13. 11066363 - Substituted 6,11-dihydro-5H-benzo[B]carbazoles as inhibitors of ALK and SRPK
14. 10975055 - Inhibitors of interleukin-1 receptor-associated kinases and uses thereof
15. 10913744 - LRRK2 inhibitors and methods of making and using the same